World's Best Scientists 2026 revealed!
John J.P. Kastelein

John J.P. Kastelein

Award Badge
Best Scientists
2025
Award Badge
Medicine
Netherlands
2026

D-Index & Metrics

Best Scientists

D-Index
182
Citations
155445
World Ranking
569
National Ranking
16

Medicine

D-Index
186
Citations
159017
World Ranking
293
National Ranking
10

John J.P. Kastelein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John J.P. Kastelein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,118 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John J.P. Kastelein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John J.P. Kastelein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 186 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Netherlands Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Netherlands Leader Award
  • 2023 - Research.com Medicine in Netherlands Leader Award
  • 2022 - Research.com Medicine in Netherlands Leader Award

Overview

John J.P. Kastelein is affiliated with the University of Amsterdam in the Netherlands. Their research primarily centers on medicine, with a significant emphasis on several subfields including surgery, endocrinology, diabetes and metabolism, economics and econometrics, cardiology and cardiovascular medicine, and cancer research. The scope of their work broadly covers topics related to lipoproteins and cardiovascular health, diabetes and cardiovascular risks, cancer and lipid metabolism, pharmaceutical economics and policy, lipid metabolism and disorders, health systems with economic evaluations and quality of life, and cholesterol and lipid metabolism.

Kastelein has contributed extensively to the scientific community with numerous publications. Frequent venues for their work include Atherosclerosis, Journal of Clinical Lipidology, Journal of the American College of Cardiology, Circulation, and the New England Journal of Medicine. This reflects a strong focus on cardiovascular and lipid-related research within both clinical and biomedical contexts.

The scientist has authored or co-authored several notable papers, including:

  • "Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol" (2020, New England Journal of Medicine)
  • "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk" (2020, JAMA)
  • "Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia" (2020, New England Journal of Medicine)
  • "Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients" (2023, New England Journal of Medicine)
  • "Evinacumab for Homozygous Familial Hypercholesterolemia" (2020, New England Journal of Medicine)

John J.P. Kastelein has collaborated frequently with a core network of coauthors, indicating ongoing professional relationships within the field of cardiovascular and lipid research. These coauthors include Marc Ditmarsch, Kausik K. Ray, Frederick J. Raal, Michael H. Davidson, and Stephen J. Nicholls.

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest

  • Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

    John C. LaRosa;Scott M Grundy;David D. Waters;Charles Shear

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Effects of Torcetrapib in Patients at High Risk for Coronary Events

    Philip J. Barter;Mark Caulfield;Mats Eriksson;Scott M Grundy

  • Discovery and refinement of loci associated with lipid levels

    Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta;Gina M. Peloso;Gina M. Peloso;Gina M. Peloso

  • Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

    Jennifer G. Robinson;Michel Farnier;Michel Krempf;Jean Bergeron

  • High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

    Terje R. Pedersen;Ole Faergeman;John J. P. Kastelein;Anders G. Olsson

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

    Heribert Schunkert;Inke R. König;Sekar Kathiresan;Muredach P. Reilly

  • HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

    Philip Barter;Antonio M. Gotto;John C. LaRosa;Jaman Maroni

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

    David Preiss;Sreenivasa Rao Kondapally Seshasai;Paul Welsh;Sabina A. Murphy

  • Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

    John J.P. Kastelein;Fatima Akdim;Erik S.G. Stroes;Aeilko H. Zwinderman

  • Genetic studies of body mass index yield new insights for obesity biology

    Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

    Paul M Ridker;Eleanor Danielson;Francisco Ah Fonseca;Jacques Genest

  • Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

    Stephen J. Nicholls;Stephen J. Nicholls;Rishi Puri;Todd Anderson;Christie M. Ballantyne

  • Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol

    Kausik K. Ray;R. Scott Wright;David Kallend;Wolfgang Koenig;Wolfgang Koenig

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

    David Preiss;Sreenivasa Rao Kondapally;Paul Welsh;Sabina A. Murphy

  • Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease

    J.C. LaRosa;S.M. Grundy;D.D. Waters

Frequent Co-Authors

Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
G. Kees Hovingh
G. Kees Hovingh University of Amsterdam
S. Matthijs Boekholdt
S. Matthijs Boekholdt University of Amsterdam
Nicholas J. Wareham
Nicholas J. Wareham University of Cambridge
Kay-Tee Khaw
Kay-Tee Khaw University of Cambridge
Michael R. Hayden
Michael R. Hayden University of British Columbia
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Eric J.G. Sijbrands
Eric J.G. Sijbrands Erasmus University Rotterdam
Kausik K. Ray
Kausik K. Ray Imperial College London
Wolfgang Koenig
Wolfgang Koenig German Heart Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative educational and career paths can be valuable for students considering Medicine in the USA. For those interested in advanced nursing roles, shortest dnp programs online allow qualified nurses to earn a Doctor of Nursing Practice degree in less time, helping them quickly step into leadership positions.

Those seeking a manageable academic workload might consider the easiest online dnp programs, which are designed for flexibility and may suit working professionals or students with other commitments.

If you’re looking to enter the healthcare workforce quickly, fast track lpn programs online can help you become a Licensed Practical Nurse in the shortest time possible, offering a stepping stone to further qualifications.

For those interested in mental health, the shortest post master's pmhnp online programs enable advanced practice nurses to specialize rapidly in psychiatric mental health.

Each of these online pathways combines flexibility and efficiency, enabling motivated individuals to launch or advance their healthcare careers alongside or as alternatives to traditional medical education.

Best Scientists Citing John J.P. Kastelein

Trending Scientists

Recently Published Articles